Modification of a domiciliary ventilator to increase FiO


Journal

Thorax
ISSN: 1468-3296
Titre abrégé: Thorax
Pays: England
ID NLM: 0417353

Informations de publication

Date de publication:
01 2021
Historique:
received: 08 06 2020
revised: 07 08 2020
accepted: 23 08 2020
pubmed: 21 10 2020
medline: 30 12 2020
entrez: 20 10 2020
Statut: ppublish

Résumé

Although nasal continuous positive airway pressure or non-invasive ventilation is used to manage some patients with acute lung injury due to COVID-19, such patients also demonstrate increased minute ventilation which makes it hard, if the device is used in line with the manufacturer's instructions, to achieve adequate oxygen delivery. In addition, if a hospital contains many such patients, then it is possible that the oxygen requirements will exceed infrastructure capacity. Here we describe a simple modification of two exemplar ventilators normally used for domiciliary ventilation, which substantially increased the fraction of inspired oxygen (FiO

Identifiants

pubmed: 33077616
pii: thoraxjnl-2020-215487
doi: 10.1136/thoraxjnl-2020-215487
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

83-85

Informations de copyright

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: MIP serves as a paid consultant for Philips and JFD.

Auteurs

Yoseph Mebrate (Y)

Department of Biomedical Engineering, Royal Brompton and Harefield NHS Foundation Trust, London, UK.

Steven Phillips (S)

Department of Biomedical Engineering, Royal Brompton and Harefield NHS Foundation Trust, London, UK.

Debbie Field (D)

Department of Respiratory Medicine, Royal Brompton and Harefield NHS Foundation Trust, London, UK.

Ivy Mumuni (I)

Department of Biomedical Engineering, Royal Brompton and Harefield NHS Foundation Trust, London, UK.

Paul Josse (P)

Department of Design, Brunel University College of Engineering Design and Physical Sciences, Uxbridge, Hillingdon, UK.

David Alexander (D)

Department of Anesthesia, Royal Brompton and Harefield NHS Foundation Trust, London, UK.

Rishi Das-Gupta (R)

Department of Innovation and Technology, Royal Brompton and Harefield NHS Foundation Trust, London, UK.

Richard Trimlett (R)

Department of Cardiothoracic Surgery, Royal Brompton and Harefield NHS Foundation Trust, London, UK.

Michael I Polkey (MI)

Department of Respiratory Medicine, Royal Brompton and Harefield NHS Foundation Trust, London, UK m.polkey@rbht.nhs.uk.
Thoracic Medicine, National Heart and Lung Institute, Imperial College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH